Startups
Piramal Pharma, headquartered in India, is a global pharmaceutical manufacturing company delivering CDMO expertise, pharma services, and healthcare solutions worldwide.
Overview
Location
India
Mentions in press and media 25
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 6, 2026 | - | The new lab more than triples the site's existing microbiology testing space, supporting improved laboratory workflow and providing additional capacity to accommodate future growth. The added space features three new biosafety cabinets... |
| Oct 6, 2026 | /C O R R E C T I O N -- Piramal Pharma Solutions/ | In the news release, Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility, issued 06-Oct-2026 by Piramal Pharma Solutions over PR Newswire, we are advised by the company that changes... |
| Sep 30, 2026 | Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month | Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facilit... |
| Sep 30, 2026 | Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility | Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innov... |
| Sep 16, 2026 | Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site | Piramal Pharma Solutions is installing a ground-mounted solar power plant (4.3 MWp) at its integrated drug substance and drug product site in Morpeth, UK. The new plant will provide renewable energy directly to the site through a behind-the... |
| Sep 14, 2026 | Piramal Pharma’s UK facility receives 7 observations from US FDA inspection | |
| Aug 26, 2026 | Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations | Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global... |
| Aug 19, 2026 | Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited | Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since 2021, enabling the Company to provide a br... |
| Aug 4, 2026 | Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite | Piramal Pharma Solutions has added a new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India, equipped with its own air handling units, nitrogen supply, and control systems. The new suite e... |
Show more
Reviews 0
FAQ about Piramal Pharma Limited
What has the press written about Piramal Pharma Limited?
Parsers VC has collected 25 articles mentioning Piramal Pharma Limited, among them “/C O R R E C T I O N -- Piramal Pharma Solutions/” (Oct 6, 2026) and “Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month” (Sep 30, 2026).
Is Piramal Pharma Limited still active?
Yes, Piramal Pharma Limited is active; its latest activity on Parsers VC dates from Oct 28, 2026.